One new alkyl benzoquinone, paphionone (1), one new trans-stilbenoid, (E)-6,5'-dihydroxy-2,3'-dimethoxystilbene (2), and eight known stilbenoids and flavonoids (3-10) were isolated from the leaves and roots of Paphiopedilum exul (Orchidaceae). Their chemical structures were determined based on IR, ECD, MS and NMR analyses. Cytotoxicity of all isolated compounds towards human hepatocellular carcinoma (HepG2) cell line was examined in vitro by MTT assay. The para-hydroxybenzyl substituted stilbene 10 was potently cytotoxic to the cancer cells, with an IC50 value of 4.80 ± 1.10 μM (selectivity index = 20.83). All compounds were non-toxic to normal human embryo fibroblast (OUMS-36) cell line.
31 October 2025 in International Journal of STD & AIDS
Background: This study investigates drug-drug interactions (DDIs) in people with HIV (PWH) receiving antiretroviral therapy (ART) with comorbidities. We focus on pharmacological factors and evaluate DDI notifications from online databases, emphasizing the clinical relevance of pharmacokinetic, pharmacodynamic, and pharmacogenomic variations. Methods: A comprehensive literature search was conducted using PubMed, ScienceDirect, Google Scholar, and the Cochrane Library for studies published between January 2019 and September 2024. Newly identified DDI evidence was analyzed by comparing DrugBank, Drugs.com, and the Liverpool HIV databases. Results: Eleven studies met the inclusion criteria. The findings of these studies showed the critical importance of considering DDIs in PWH with tuberculosis (TB), malaria, and pulmonary hypertension. Severe adverse drug reactions associated with ARTs, including efavirenz, darunavir, nevirapine, and atazanavir-ritonavir, especially when combined with treatments for TB and malaria. Key interactions included reduced drug levels from rifampicin and QT prolongation from artemether-lumefantrine. Pharmacogenomic factors, such as CYP2B6 slow metabolism during pregnancy, influenced outcomes. Database discrepancies were noted, especially for riociguat interactions and ritonavir through inhibition of P-gp or OATP1B1 functions. Conclusions: DDIs in PWH receiving ART with comorbidities have highlighted the crucial need for personalized treatment. Incorporating pharmacokinetic, pharmacodynamic, and pharmacogenomic factors is essential for optimizing therapy outcomes.
A new trans-stilbene, (E)-2,4-bis(4-hydroxybenzyl)-3,5-dihydroxystilbene (1), and ten known compounds including stilbenoids (2, 7, 8, 10), coumaric acid ester (3), flavonoids (4-6), aromatic aldehyde (9) and triterpenoid glycoside (11) were isolated from the leaves and roots of the lady slipper's orchid Paphiopedilum hirsutissimum (Lindl. ex Hook.) Stein. The structures of these chemical constituents were determined based on their spectroscopic data and comparison with literature. In vitro cytotoxicity of all isolated compounds towards human hepatic cancer (HepG2) cell line was examined by MTT assay. Izalpinin (6) was potently cytotoxic to the cancer cells, with an IC50 value of 4.62 ± 1.50 μM. Stilbenoids 2, 7 and 8 also exhibited notable activity in the range of 6.31-6.68 μM. All compounds, except the new stilbene 1, were non-toxic to normal fibroblast (OUMS-36) cell line.